Remove Food and Drug Administration Remove Government Remove Patients Remove Prescription
article thumbnail

What do future healthcare CEOs look like?

World of DTC Marketing

I have to laugh when I hear that a pharma company is patient-centric because that’s become a slogan to make employees feel good about themselves while the costs of prescription drugs increase every year. drug spending by 9 percent” What about taxpayers? Gilead Sciences, Daniel O’Day — $29.1

article thumbnail

What Pear Therapeutics’ Bankruptcy Has Left the DTX Industry to Ponder

MedCity News

During Covid-19, governing agencies loosened regulatory requirements and increased incentives for DTx. The goal was simple: provide access and focused support to patients remotely while simultaneously relieving overtaxed healthcare facilities. An added benefit was the application of decentralized clinical trials (DCTs) to DTx.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The internet enables misinformation on COVID

World of DTC Marketing

While patients have the right to full disclosure, misinformation and scare tactics could lead to more deaths from COVID. Also cited was a lack of trust in the government to ensure the vaccines’ safety and effectiveness. The government allowed the drugmakers to mass-produce the vaccine while still conducting clinical trials.

article thumbnail

Clinical Research News: Social Determinants Of Health Data Help Identify Sites For Trials

Clarify Health

Earlier this year, Clarify Health began offering a new service ( Clarify Trials ) whereby companies could receive a list of the most-ideal sites for studies tied to the characteristics of patients they hope to enroll. Data governance and HIPAA rules around this are very clear—you can’t identify the individual.

article thumbnail

Diversity and inclusion in oncology clinical trials

Clarify Health

Food and Drug Administration (FDA) released guidance entitled, Enhancing the Diversity of Clinical Trial Populations — Eligibility Criteria, Enrollment Practices, and Trial Designs Guidance for Industry. To advance equity in clinical research, the U.S. However, another study found that 0.1% 2] Figure 1. 2] Figure 1.

article thumbnail

Clinical Research News: Social Determinants Of Health Data Help Identify Sites For Trials

Clarify Health

Earlier this year, Clarify Health began offering a new service ( Clarify Trials ) whereby companies could receive a list of the most-ideal sites for studies tied to the characteristics of patients they hope to enroll. Data governance and HIPAA rules around this are very clear—you can’t identify the individual.

article thumbnail

Pharma dodges a bullet, for now

World of DTC Marketing

Medicare’s innovation center may be the best avenue for lowering drug costs if provisions empowering government price negotiation don’t’ make it into a sweeping domestic spending package. For now, drug companies are free to overcharge Medicare for prescription drugs.